An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States
Clinical trial NCT00237263 · COMPLETED
Trial details
- NCT number
- NCT00237263
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2007-07-01
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.